A group of cardiac surgeons and general cardiologists critical of what they believe is biased data in coronary and structural heart disease has founded a group called the International Evidence Grading Research Initiative Targeting Transparency and Data Quality (INTEGRITTY). The group aims to shed light on how certain clinical trials are conducted, including the recent ACC/AHA/SCAI guidelines for coronary revascularization and clinical trial on the treatment of left main disease, and how conflicts of interest can skew the data and negatively impact patient care.